SCHEMBL31664549

SCHEMBL31664549

C=CC(=O)Nc1ccccc1-c1c(CC)nc2n(CC(=O)Nc3ccc(C(F)(F)F)cc3)c(-c3cccs3)nn2c1=O

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 2/20 0.36
▸ AKR1B1 P15121 1/20 0.36
▸ RORC P51449 3/20 0.35
▸ TDP1 Q9NUW8 2/20 0.35
▸ POLB P06746 1/20 0.35
▸ KDM4E B2RXH2 3/20 0.35
▸ KMT2A Q03164 3/20 0.35
▸ LMNA P02545 1/20 0.35
▸ HPGD P15428 1/20 0.35
▸ HTT P42858 1/20 0.35
▸ TGM2 P21980 1/20 0.35
▸ MAP3K7 O43318 1/20 0.35
▸ FGFR1 P11362 1/20 0.35
▸ SRC P12931 1/20 0.35
▸ ALDH1A1 P00352 1/20 0.34
▸ HSD17B10 Q99714 2/20 0.33
▸ ALOX15 P16050 1/20 0.33
▸ SMN1; SMN2 Q16637 1/20 0.33
▸ MEN1 O00255 1/20 0.33
▸ ELANE P08246 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31664573 0.90 AKR1B1 (0.39) MAPTAKR1B1RORCTDP1POLB
SCHEMBL31713828 0.86 HSD17B10 (0.36) MAPTAKR1B1RORCTDP1POLB
SCHEMBL31664538 0.85 MAPT (0.37) MAPTAKR1B1RORCTDP1POLB
SCHEMBL31664566 0.84 MAPT (0.36) MAPTAKR1B1RORCTDP1POLB
SCHEMBL31664545 0.83 MAPT (0.36) MAPTAKR1B1RORCTDP1POLB
SCHEMBL31677868 0.83 RORC (0.40) MAPTAKR1B1RORCTDP1POLB
SCHEMBL31713931 0.82 MAPT (0.39) MAPTAKR1B1RORCTDP1POLB
SCHEMBL31677784 0.82 MAPT (0.39) MAPTAKR1B1RORCTDP1POLB
SCHEMBL31653782 0.82 MAPT (0.42) MAPTAKR1B1RORCTDP1POLB
SCHEMBL31678236 0.81 KDM4E (0.39) MAPTAKR1B1RORCTDP1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250236622-A1 BICYCLIC COMPOUNDS AS INHIBITORS OF WRN INCYTE CORPORATION (US) 2025-07-24 — — US claimed
US-20250236622-A1 BICYCLIC COMPOUNDS AS INHIBITORS OF WRN INCYTE CORPORATION (US) 2025-07-24 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250236622-A1 BICYCLIC COMPOUNDS AS INHIBITORS OF WRN WRN, BLM, RECQL MAPT 4634/4885AKR1B1 2734/4885RORC 1423/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback